Dominik Hochli

All filings by Dominik Hochli on record concern Abivax, in the capacity of board member. We count 2 filings; the first trade dates from 7 May 2025 and the latest from 17 February 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 19 February 2026, reports a transaction of €50k in Abivax. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.